Formulation of medicines for children

British Journal of Clinical Pharmacology

Volumn 59, Issue 6, 2005, Pages 674-676

  Nunn, Tony ^a   Williams, Julie ^b  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Child; Dosage form; Formulation; Paediatric

Indexed keywords

ANTIOXIDANT; BUFFER; CALPOL FAST MELTS; DIPHENHYDRAMINE; EXCIPIENT; IBUPROFEN; MONTELUKAST; NARATRIPTAN; NELFINAVIR; NEW DRUG; NON PRESCRIPTION DRUG; NUROFEN MELTLETS; OLANZAPINE; ONDANSETRON; ORALSOLV; PARACETAMOL; PRESERVATIVE; SUMATRIPTAN; SWEETENING AGENT; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; WOWTAB;

ACCURACY; ADOLESCENT; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRUG SYNTHESIS; ENCAPSULATION; GEL; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TABLET; TASTE; TRANSDERMAL PATCH;

ADOLESCENT; AGING; CHEMISTRY, PHARMACEUTICAL; CHILD; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 20644436474     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02410.x     Document Type: Review

References (1)

1. Tan E, Cranswick NE, Rayner CR, Chapman CB. Dosing information for paediatric patients: are they really 'therapeutic orphans'? Med J Aust 2003; 179 (4): 195-8.